Skip to main content

VALHI INC /DE/

For the period ended Jun 30, 2025. Filed Aug 7, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 7, 2025

VHI$16.22+0.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Notes to Condensed Consolidated Financial Statements (unaudited)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2025

(unaudited)

Note 1 – Organization and basis of presentation:

Organization**–**We are majority owned by a wholly-owned subsidiary of Contran Corporation (“Contran”), which owns approximately 91% of our outstanding common stock at June 30, 2025. A majority of Contran’s outstanding voting stock is held directly by Lisa K. Simmons and by family stockholders (Thomas C. Connelly (the husband of Ms. Simmons’ late sister), a family-owned entity and various family trusts established for the benefit of Ms. Simmons, Mr. Connelly and their children) who are required to vote their shares of Contran voting stock in the same manner as Ms. Simmons. Such voting rights are personal to Ms. Simmons and last through April 22, 2030. The remainder of Contran’s outstanding voting stock is held by another trust (the “Family Trust”), which was established for the benefit of Ms. Simmons and her late sister and their children and for which a third-party financial institution serves as trustee. Consequently, at June 30, 2025, Ms. Simmons and the Family Trust may be deemed to control Contran and us.

*Basis of Presentation –*Consolidated in this Quarterly Report are the results of our wholly-owned and majority-owned subsidiaries, including NL Industries, Inc., Kronos Worldwide, Inc., CompX International Inc., Tremont LLC, Basic Management, Inc. (“BMI”) and The LandWell Company (“LandWell”). Kronos (NYSE: KRO), NL (NYSE: NL) and CompX (NYSE American: CIX) each file periodic reports with the Securities and Exchange Commission (“SEC”).

The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2024 that we filed with the SEC on March 6, 2025 (the “2024 Annual Report”). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments), in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December 31, 2024 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2024) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Our results of operations for the interim periods ended June 30, 2025 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2024 Consolidated Financial Statements contained in our 2024 Annual Report.

Effective July 16, 2024 (“Acquisition Date”), Kronos acquired the 50% joint venture interest in Louisiana Pigment Company, L.P. (“LPC”) previously held by Venator Investments, Ltd. (“Venator”). Prior to the acquisition, Kronos held a 50% joint venture interest in LPC and LPC was operated as a manufacturing joint venture between Kronos and Venator. Following the acquisition, LPC became a wholly-owned subsidiary of Kronos. For financial reporting purposes, the assets acquired and liabilities assumed of LPC have been included in our Condensed Consolidated Balance Sheets as of December 31, 2024 and June 30, 2025, and the results of operations and cash flows of LPC have been included in our Condensed Consolidated Statement of Income and Cash Flows beginning as of the Acquisition Date. See Note 18 to our Condensed Consolidated Financial Statements.

Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Valhi, Inc. and its subsidiaries (NYSE: VHI), taken as a whole.

Note 2 – Business segment information:

​ · ​ · ​ · ​ · ​ · ​
​ · ​ · % controlled at
Business segment · ​ · Entity · ​ · June 30, 2025
ChemicalsKronos81%​
Component productsCompX87%​
Real estate management and developmentBMI and LandWell63% - 77%​

Our control of Kronos includes approximately 50% we hold directly and approximately 31% held directly by NL. We own approximately 83% of NL. Our control of CompX is through NL. We own approximately 63% of BMI. Our control of LandWell includes the approximately 27% we hold directly and 50% held by BMI.

Our chief operating decision maker (“CODM”) evaluates segment performance based on each segment’s operating income, which is defined as income before income taxes and interest expense, exclusive of certain non-recurring items (such as gains or losses on disposition of business units and other long-lived assets outside the ordinary course of business and certain legal settlements) and certain general corporate income and expense items (including securities transactions gains and losses and interest and dividend income), which are not attributable to the operations of the reportable operating segments. Interest income included in the calculation of segment operating income is not significant for the three and six months ended June 30, 2024 and 2025.

​​​​​​​​​​​​​
​ · ​ · Three months ended · ​ · Six months ended
​ · ​ · June 30, · ​ · June 30,
​ · 2024 · 2025 · 2024 · 2025
​​(In millions)
Net sales:​​​​​​​​​​​​
Chemicals​$500.5​$494.4​$979.3​$984.2
Component products​35.9​40.3​73.9​80.6
Real estate management and development​23.3​5.7​37.1​14.2
Total net sales​$559.7​$540.4​$1,090.3​$1,079.0
Cost of sales:​​​​
Chemicals​$400.7​$432.1​$808.6​$815.5
Component products​24.8​27.4​53.1​55.5
Real estate management and development​12.9​2.8​21.0​7.4
Total cost of sales​$438.4​$462.3​$882.7​$878.4
Gross margin:​​​​
Chemicals​$99.8​$62.3​$170.7​$168.7
Component products​11.1​12.9​20.8​25.1
Real estate management and development​10.4​2.9​16.1​6.8
Total gross margin​$121.3​$78.1​$207.6​$200.6
Operating income:​​​​
Chemicals​$40.5​$10.3​$63.3​$51.5
Component products​5.1​6.3​8.8​12.2
Real estate management and development​9.2​18.9​14.2​21.9
Total operating income​54.8​35.5​86.3​85.6
General corporate items:​​​​
Interest income and other​​5.5​​3.7​​11.2​​8.0
Other components of net periodic pension and OPEB expense​(.6)​(.7)​(1.2)​(1.5)
Changes in market value of Valhi common stock held by subsidiaries​.1​—​.6​(1.7)
General expenses, net​(10.3)​(9.2)​(18.1)​(17.1)
Interest expense​(11.9)​(13.8)​(23.2)​(27.0)
Income before income taxes​$37.6​$15.5​$55.6​$46.3
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Three months ended · ​ · Six months ended
​ · ​ · June 30, · ​ · June 30,
​ · 2024 · 2025 · 2024 · 2025
​ · ​ · (In millions)
Depreciation and amortization: · ​ · ​ · ​ · ​
Chemicals​$19.0​$15.6​$30.5​$30.0
Component products​.9​.9​1.8​1.9
Real estate management and development​—​—​.1​—
Total​$19.9​$16.5​$32.4​$31.9

Included in the Chemicals Segment’s operating income for the three and six month periods ended June 30, 2024 is a charge of approximately $2 million related to workforce reductions and approximately $10 million in non-cash charges primarily related to accelerated depreciation in connection with the closure of its sulfate process line in Canada in the second quarter of 2024. Infrastructure reimbursements and land related income is included in the determination of Real Estate Management and Development operating income. See Note 12. Segment results we report may differ from amounts separately reported by our various subsidiaries due to purchase accounting adjustments and related amortization or differences in the way we define operating income. Intersegment sales are not material. Our CODM is not regularly provided financial information related to the assets of the reportable segments, including capital

expenditures, and he does not evaluate the reportable segments’ performance or allocate resources to them based on assets. Therefore, total assets by reportable segment are not included in our segment disclosures.

Note 3 – Accounts and other receivables, net:

​​​​​​​
​ · ​ · December 31, · ​ · June 30,
​ · 2024 · 2025
​ · ​ · (In millions)
Trade accounts receivable: · ​ · ​
Kronos​$269.2​$320.9
CompX​14.2​17.0
BMI/LandWell​.3​1.2
VAT and other receivables​45.9​37.7
Refundable income taxes​​1.3​​3.2
Receivables from affiliates:​​​​​​
Contran - income taxes​​—​​3.2
Contran - trade items​​.2​​.1
Other​​.6​​.2
Allowance for doubtful accounts​(3.9)​(4.3)
Total​$327.8​$379.2

Note 4 – Inventories, net:

​ · ​ · ​ · ​ · ​ · ​ · ​
​​December 31,​June 30,
​ · 2024 · 2025
​ · ​ · (In millions)
Raw materials: · ​ · ​
Chemicals​$176.9​$142.8
Component products​5.6​5.8
Total raw materials​182.5​148.6
Work in process:​​
Chemicals​52.5​49.2
Component products​17.6​22.2
Total in-process products​70.1​71.4
Finished products:​​
Chemicals​308.3​359.8
Component products​5.1​4.9
Total finished products​313.4​364.7
Supplies (chemicals)​119.8​132.5
Total​$685.8​$717.2

Note 5 – Marketable securities:

​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · Cost or · ​ · ​ · ​
​ · ​ · ​ · ​ · ​ · amortized · ​ · Unrealized
​ · ​ · Market value · ​ · cost · ​ · gain, net
​ · ​ · (In millions)
December 31, 2024: · ​ · ​ · ​
Current assets​$1.9​$1.9​$—
​​​​​​​​​​
Noncurrent assets​$5.7​$5.7​$—
​​​​​​​​​​
June 30, 2025:​​​
Current assets​$2.4​$2.4​$—
​​​​​​​​​​
Noncurrent assets​$4.7​$4.5​$.2

Our marketable securities consist of investments in marketable equity and debt securities. We classify all of our marketable securities as available-for-sale. Our marketable equity securities are carried at fair value using quoted market prices, primarily Level 1 inputs as defined by ASC Topic 820,Fair Value Measurements and Disclosures, with any unrealized gains or losses on the securities recognized in other income, net on our Condensed Consolidated Statements of Income. The fair value of our marketable debt securities is generally determined using Level 2 inputs because although these securities are traded in many cases, the market is not active and the quarter-end valuation is generally based on the last trade of the quarter, which may be several days prior to quarter end. We accumulate unrealized gains and losses on marketable debt securities as part of accumulated other comprehensive income (loss), net of related deferred income taxes. See Note 17.

Note 6 – Other noncurrent assets:

​​​​​​​
​ · December 31, · June 30,
​ · ​ · 2024 · ​ · 2025
​ · ​ · (In millions)
Note receivables - OPA​$91.6​$102.8
Pension asset​19.8​21.9
Operating lease right-of-use assets​20.6​21.5
IBNR receivables​15.0​15.1
Restricted cash and cash equivalents​​5.5​​6.0
Land held for development​​7.4​​5.9
Other​21.4​16.8
Total​$181.3​$190.0

Note 7 – Long-term debt:

​​​​​​​
​ · ​ · December 31, · ​ · June 30,
​ · 2024 · 2025
​ · ​ · (In millions)
Valhi: · ​ · ​
Contran credit facility​$44.6​$33.1
Subsidiary debt:​​
Kronos:​​
Kronos International, Inc. 9.50% Senior Secured Notes due 2029​​365.4​​410.7
Kronos International, Inc. 3.75% Senior Secured Notes due 2025​78.3​87.9
Subordinated, Unsecured Term Loan from Contran​​53.7​​53.7
Revolving credit facility​​10.0​​37.0
LandWell:​​
Note payable to Western Alliance Business Trust​11.4​11.1
Total subsidiary debt​518.8​600.4
Total debt​563.4​633.5
Less current maturities​79.0​88.7
Total long-term debt​$484.4​$544.8

Valhi –* Contran credit facility* – During the first six months of 2025, we hadno borrowings and repaid $11.5 million under this facility. The average interest rate on the credit facility for the six months ended June 30, 2025 was 8.50%. At June 30, 2025, the interest rate was 8.50%, and $116.9 million was available for borrowing under this facility.

Kronos*–9.50% Senior Secured Notes due 2029* – At June 30, 2025, the carrying value of the 9.50% Senior Secured Notes due 2029 (€351.174 million aggregate principal amount outstanding) is $410.7 million and is stated net of $5.2 million of unamortized premium and $6.2 million of unamortized debt issuance costs. In the first quarter of 2024 Kronos recognized a non-cash pre-tax interest charge of $1.5 million included in interest expense related to the write-off of deferred financing costs.

3.75%* Senior Secured Notes due 2025* – At June 30, 2025, the carrying value of the 3.75% Senior Secured Notes due 2025 (€75 million aggregate principal amount outstanding) is $87.9 million.

*Revolving credit facility (the “Global Revolver”) –*Effective July 17, 2025, Kronos completed an amendment to its Global Revolver (the “Fourth Amendment”). Among other things, the Fourth Amendment increased the maximum borrowing amount from

$300 million to $350 million and increased the Belgian and German sub-limits from €30 million and €60 million to €55 million and €85 million, respectively, allowing greater access to Euro denominated borrowings. The maturity date of the Global Revolver remains July 2029. After taking into consideration the effects of the Fourth Amendment, Kronos’ total availability for borrowing has increased by approximately $50 million. During the first six months of 2025, Kronos borrowed $314.1 million and repaid $287.1 million under this facility. The average interest rate on outstanding borrowings under this facility for the six months ended June 30, 2025 was 5.9%. At June 30, 2025, $37.0 million was outstanding under the Global Revolver and the average interest rate was 5.8%. As defined in the agreement and as calculated for the period ended June 30, 2025, the borrowing base exceeded $350 million. At June 30, 2025, Kronos had total availability for borrowing of approximately $300 million less any amounts outstanding under this facility.

Other* –* We are in compliance with all of our debt covenants at June 30, 2025.

Note 8 – Accounts payable and accrued liabilities:

​​​​​​​
​ · ​ · December 31, · ​ · June 30,
​ · 2024 · 2025
​ · ​ · (In millions)
Accounts payable: · ​ · ​
Kronos​$232.4​$187.0
CompX​3.7​4.1
BMI/LandWell​8.0​3.1
Distributions payable to noncontrolling interest​5.9​1.0
Total​​250.0​​195.2
Payables to affiliates:​​​​​​
Contran - income taxes​​16.9​​—
Contran - other​​.2​​1.3
Employee benefits​​38.7​​35.1
Deferred income​​28.2​​27.4
Accrued development costs​​30.0​​22.4
Accrued sales discounts and rebates​27.6​17.0
Accrued litigation settlement​​16.4​​16.6
Interest​11.4​12.5
Operating lease liabilities​3.5​4.2
Other​59.7​49.0
Total​$482.6​$380.7

The accrued litigation settlement is discussed in Note 16.

Note 9 – Other noncurrent liabilities:

​​​​​​​
​ · December 31, · June 30,
​ · ​ · 2024 · ​ · 2025
​ · ​ · (In millions)
Accrued development costs​$26.8​$24.7
Operating lease liabilities​​17.1​​17.1
Insurance claims and expenses​16.6​16.6
Asset retirement obligations​​14.3​​16.2
Deferred income​​11.8​​8.0
Other postretirement benefits​6.7​7.0
Employee benefits​4.5​5.0
Earn-out liability​​4.3​​4.6
Other​.6​.5
Total​$102.7​$99.7

See Notes 17 and 18 for additional details related to the acquisition earn-out liability.

Note 10 – Revenue – disaggregation of sales:

The following table disaggregates the net sales of our Chemicals Segment by place of manufacture (point of origin) and to the location of the customer (point of destination), which are the categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

​​​​​​​​​​​​​
​ · ​ · Three months ended · ​ · Six months ended
​ · ​ · June 30, · ​ · June 30,
​ · 2024 · 2025 · 2024 · 2025
​ · ​ · (In millions)
Net sales - point of origin: · ​ · ​ · ​ · ​
United States​$279.7​$275.7​$520.6​$598.1
Germany​​216.2​​214.5​​428.4​​431.3
Canada​97.6​55.7​186.9​166.5
Norway​77.7​72.8​148.7​143.3
Belgium​61.0​65.6​130.6​131.3
Eliminations​(231.7)​(189.9)​(435.9)​(486.3)
Total​$500.5​$494.4​$979.3​$984.2
​​​​​​​​​​​​​
Net sales - point of destination:​​​​
Europe​$222.6​$226.8​$437.5​$455.3
North America​182.5​188.2​348.5​378.4
Other​95.4​79.4​193.3​150.5
Total​$500.5​$494.4​$979.3​$984.2

The following table disaggregates the net sales of our Component Products Segment by major product line.

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Three months ended · ​ · Six months ended
​ · ​ · June 30, · ​ · June 30,
​ · 2024 · 2025 · 2024 · 2025
​ · ​ · (In millions)
Net sales: · ​ · ​ · ​ · ​
Security products​$28.2​$30.7​$58.1​$60.9
Marine components​7.7​9.6​15.8​19.7
Total​$35.9​$40.3​$73.9​$80.6

Substantially all of the Real Estate Management and Development Segment’s sales are related to land sales in the second quarter and the first six months of 2024 and 2025.

Note 11 – Defined benefit pension plans:

NL administers a U.S. pension plan which has been closed to new participants since 1996. In accordance with applicable U.S. pension regulations, effective June 30, 2025 NL began the process of terminating the pension plan, which includes the purchase of annuity contracts from a third-party insurance company for the purpose of distributing benefits to plan participants. The termination process involves several steps and is expected to take between six and twelve months to complete. Following the purchase of the annuity contracts for plan participants we will remove pension plan assets and liabilities from our Condensed Consolidated Financial Statements and a plan settlement gain or loss (which we are currently unable to estimate) will be included in our net periodic pension cost. The plan termination is expected to be completed with existing plan funds. At December 31, 2024 the U.S. pension plan had a benefit obligation of $65.2 million, plan assets of $75.7 million and a pension plan asset of $10.7 million.

The components of our net periodic defined benefit pension cost are presented in the table below.

​​​​​​​​​​​​​
​ · ​ · Three months ended · ​ · Six months ended
​ · ​ · June 30, · ​ · June 30,
​ · 2024 · 2025 · 2024 · 2025
​ · ​ · (In millions)
Service cost​$1.6​$1.5​$3.3​$2.9
Interest cost​​5.2​​5.8​​10.6​​11.3
Expected return on plan assets​(5.6)​(5.9)​(11.2)​(11.4)
Recognized net actuarial losses​1.0​.9​1.9​1.6
Total​$2.2​$2.3​$4.6​$4.4

We expect to contribute the equivalent of approximately $16 million to all of our defined benefit pension plans during 2025.

Note 12 – Other income, net:

​​​​​​​
​ · ​ · Six months ended
​ · ​ · June 30,
​ · 2024 · 2025
​ · ​ · (In millions)
Interest income and other: · ​ · ​
Interest and dividends$11.0$7.8
Securities transactions, net​​.2​​.2
Total​​11.2​​8.0
Infrastructure reimbursement​​—​​17.5
Currency transactions, net​​2.0​​5.0
Other, net​​2.7​​1.4
Total​$15.9​$31.9

Infrastructure reimbursement–* *As disclosed in Note 7 to our 2024 Annual Report, under an Owner Participation Agreement (“OPA”) entered into by LandWell with the Redevelopment Agency of the City of Henderson, Nevada, as LandWell develops certain real property for commercial and residential purposes in its master planned community in Henderson, Nevada, the cost of certain public infrastructure may be reimbursed to LandWell through tax increment. LandWell received $17.2 million during the second quarter of 2025 which was recognized as other income and is evidenced by a promissory note issued to LandWell by the City of Henderson.

LandWell has agreements with certain utility providers servicing the Cadence master planned community under which certain costs incurred for the development of power infrastructure may be reimbursed to LandWell. LandWell received $.3 million in reimbursement during the second quarter of 2025 for past costs incurred.

Note 13 – Income taxes:

​​​​​​​​​​​​​
​ · ​ · Three months ended · ​ · Six months ended
​ · ​ · June 30, · ​ · June 30,
​ · 2024 · 2025 · 2024 · 2025
​ · ​ · (In millions)
Expected tax expense at U.S. federal statutory income tax rate of 21%$7.9​$3.2​$11.7​$9.7
Non-U.S. tax rates​(.1)​(.3)​(.1)​.2
Incremental net tax benefit on earnings and losses of U.S. and non-U.S. tax group companies and other affiliates​(3.5)​(2.1)​(4.3)​(2.5)
Global intangible low-taxed income, net​1.1​1.9​1.4​2.5
Valuation allowance, net​​1.7​​5.3​​2.5​​5.5
Nondeductible expenses​​.4​​.8​​.6​​1.3
U.S. state income taxes and other, net​​.4​​(.8)​​.5​​(.7)
Income tax expense​$7.9​$8.0​$12.3​$16.0
​​​​​​​​​​​​​
Comprehensive provision for income taxes allocable to:​​​​
Net income​$7.9​$8.0​$12.3​$16.0
Other comprehensive income (loss):​​​​
Currency translation​.2​1.7​(2.1)​3.6
Pension plans​.3​.2​.6​.4
Other​(.1)​—​(.2)​—
Total​$8.3​$9.9​$10.6​$20.0

The amount shown in the preceding table of our income tax rate reconciliation for non-U.S. tax rates represents the result determined by multiplying the pre-tax earnings or losses of each of our non-U.S. subsidiaries by the difference between the applicable statutory income tax rate for each non-U.S. jurisdiction and the U.S. federal statutory tax rate. The amount shown on such table for incremental net tax benefit on earnings and losses on non-U.S. and non-tax group companies includes, as applicable, (i) deferred income taxes (or deferred income tax benefits) associated with the current year earnings (losses) of all our Chemicals Segment’s non-U.S. subsidiaries, (ii) current U.S. income taxes (or current income tax benefit) including U.S. personal holding company tax, as applicable, attributable to current-year income (losses) of one of our Chemicals Segment’s non-U.S. subsidiaries, which subsidiary is treated as a dual resident for U.S. income tax purposes, to the extent the current year income (losses) of such subsidiary is subject to U.S. income tax under the U.S. dual-resident provisions of the Internal Revenue Code, (iii) deferred income taxes associated with our direct investment in Kronos and (iv) current and deferred income taxes associated with distributions and earnings from our investments in LandWell and BMI.

Tax authorities are examining certain of our U.S. and non-U.S. income tax returns and may propose tax deficiencies, including penalties and interest. We believe we have adequate accruals for additional taxes and related interest expense which could ultimately result from tax examinations. We believe the ultimate disposition of tax examinations should not have a material adverse effect on our consolidated financial position, results of operations or liquidity. Excluding any potential adjustments resulting from on-going examinations by tax authorities, we currently estimate that our unrecognized tax benefits will not change materially during the next twelve months.

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was signed into law in the United States. The OBBBA, among other provisions, provides for bonus depreciation of qualified property, permanently modifies the interest expense deduction to use an adjusted taxable income based on a calculation similar to EBITDA and other computational changes, and makes changes to the international tax framework. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. We are in the process of evaluating the impact of the provisions of the OBBBA on our consolidated financial statements.

On July 18, 2025, Germany enacted legislation which includes, among other provisions, an additional depreciation allowance for certain fixed assets, improvements to the research and development tax allowance and, starting in 2028, a reduction of the 15% corporate tax rate byone percentage point in each of five years until the tax rate reaches 10% in 2032. We have significant German corporate net operating loss carryforwards and we expect to record deferred income tax expense of between $20 million and $23 million in the third quarter of 2025 to reduce our net deferred tax assets as a result of the reduction of the German corporate tax rate.

Note 14 – Noncontrolling interest in subsidiaries:

​ · ​ · ​ · ​ · ​ · ​ · ​
​​December 31,​June 30,
​ · 2024 · 2025
​ · (In millions)
Noncontrolling interest in net assets: · ​ · ​
Kronos Worldwide​$210.3​$215.9
NL Industries​81.5​81.7
CompX International​19.0​19.4
BMI​18.7​22.0
LandWell​13.5​19.5
Total​$343.0​$358.5
​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Six months endedJune 30,
​ · 2024 · 2025
​ · ​ · (In millions)
Noncontrolling interest in net income of subsidiaries: · ​ · ​
Kronos Worldwide​$5.1​$1.6
NL Industries​2.5​.2
CompX International​1.1​1.4
BMI​2.7​3.3
LandWell​4.2​6.0
Total​$15.6​$12.5

Note 15 – Stockholders’ equity:

Accumulated other comprehensive loss– Changes in accumulated other comprehensive income (loss) attributable to Valhi stockholders are presented in the table below.

​​​​​​​​​​​​​
​ · ​ · Three months ended · ​ · Six months ended
​ · ​ · June 30, · ​ · June 30,
​ · 2024 · 2025 · 2024 · 2025
​ · ​ · (In millions)
Accumulated other comprehensive income (loss) (net of tax and noncontrolling interest):​​​​
Marketable securities:​​​​​​​​​​​​
Balance at beginning and end of period​$1.7​$1.7​$1.7​$1.7
​​​​​​​​​​​​​
Currency translation:​​​​
Balance at beginning of period​$(102.4)​$(100.3)​$(88.8)​$(111.7)
Other comprehensive income (loss) arising during the period​1.2​9.5​(12.4)​20.9
Balance at end of period​$(101.2)​$(90.8)​$(101.2)​$(90.8)
​​​​​​​​​​​​​
Defined benefit pension plans:​​​​
Balance at beginning of period​$(58.3)​$(48.9)​$(58.8)​$(49.4)
Other comprehensive income:​​​​
Amortization of prior service cost and net losses included in net periodic pension cost​.5​.4​1.0​.9
Balance at end of period​$(57.8)​$(48.5)​$(57.8)​$(48.5)
​​​​​​​​​​​​​
OPEB plans:​​​​
Balance at beginning of period​$.4​$.1​$.4​$.2
Other comprehensive income:​​​​
Amortization of prior service credit and net losses included in net periodic OPEB cost​(.1)​—​(.1)​(.1)
Balance at end of period​$.3​$.1​$.3​$.1
​​​​​​​​​​​​​
Total accumulated other comprehensive loss:​​​​
Balance at beginning of period​$(158.6)​$(147.4)​$(145.5)​$(159.2)
Other comprehensive income (loss)​1.6​9.9​(11.5)​21.7
Balance at end of period​$(157.0)​$(137.5)​$(157.0)​$(137.5)

Note 16 – Commitments and contingencies:

Lead pigment litigation – NL

NL’s former operations included the manufacture of lead pigments for use in paint and lead-based paint. NL, other former manufacturers of lead pigments for use in paint and lead-based paint (together, the “former pigment manufacturers”), and the Lead Industries Association (“LIA”), which discontinued business operations in 2002, have previously been named as defendants in various legal proceedings seeking damages for personal injury, property damage and governmental expenditures allegedly caused by the use of lead-based paints. Certain of these actions were filed by or on behalf of states, counties, cities or their public housing authorities and school districts, and certain others were asserted as class actions. NL currently has no pending lead paint class action cases or pending lead paint cases brought by housing authorities, school districts or other government entities.

In the terms of theCounty of Santa Clara v. Atlantic Richfield Company, et al.(Superior Court of the State of California, County of Santa Clara, Case No. 1-00-CV-788657) global settlement agreement, NL has one installment payment of $16.7 million remaining which is due in September 2025. The remaining installment will be made with funds already on deposit at the court, which are included in current restricted cash on our Condensed Consolidated Balance Sheets, that are committed to the settlement, including all accrued interest at the date of payment. The amounts on deposit with the court are in excess of the final payment and such excess will be returned to NL. See Note 18 to our 2024 Annual Report.

New cases may continue to be filed against NL. We do not know if we will incur liability in the future in respect to any of the pending or possible litigation in view of the inherent uncertainties involved in court and jury rulings. In the future, if new information regarding such matters becomes available to us (such as a final, non-appealable adverse verdict against NL or otherwise ultimately being found liable with respect to such matters), at that time we would consider such information in evaluating any remaining cases then-pending against NL as to whether it might then have become probable we have incurred liability with respect to these matters, and whether such liability, if any, could have become reasonably estimable. The resolution of any of these cases could result in the recognition of a loss contingency accrual that could have a material adverse impact on our net income for the interim or annual period during which such liability is recognized and a material adverse impact on our consolidated financial condition and liquidity.

Environmental matters and litigation

Our operations are governed by various environmental laws and regulations. Certain of our businesses are and have been engaged in the handling, manufacture or use of substances or compounds that may be considered toxic or hazardous within the meaning of applicable environmental laws and regulations. As with other companies engaged in similar businesses, certain of our past and current operations and products have the potential to cause environmental or other damage. Our businesses have implemented and continue to implement various policies and programs in an effort to minimize these risks. Our policy is to maintain compliance with applicable environmental laws and regulations at all of our plants and to strive to improve environmental performance and overall sustainability. Periodically we produce our Kronos Environmental Social Governance Report, which highlights Kronos’ focus on sustainability of its manufacturing operations, as well as its environmental, social and governance strategy. From time to time, our businesses may be subject to environmental regulatory enforcement under U.S. and non-U.S. statutes, the resolution of which typically involves the establishment or enhancement of compliance programs. It is possible that future developments, such as stricter requirements of environmental laws and enforcement policies, could adversely affect our production, handling, use, storage, transportation, sale or disposal of such substances. We believe all of our facilities are in substantial compliance with applicable environmental laws.

Certain properties and facilities used in our former operations (primarily NL’s former operations), including divested primary and secondary lead smelters and former mining locations, are the subject of civil litigation, administrative proceedings or investigations arising under federal and state environmental laws and common law. Additionally, in connection with past operating practices, we are currently involved as a defendant, potentially responsible party (“PRP”) or both, pursuant to the Comprehensive Environmental Response, Compensation and Liability Act, as amended by the Superfund Amendments and Reauthorization Act (“CERCLA”), and similar state laws in various governmental and private actions associated with waste disposal sites, mining locations, and facilities that we or our predecessors, and NL or its predecessors, our subsidiaries or their predecessors currently or previously owned, operated or used, certain of which are on the United States Environmental Protection Agency’s (“EPA”) Superfund National Priorities List or similar state lists. These proceedings seek cleanup costs, damages for personal injury or property damage and/or damages for injury to natural resources. Certain of these proceedings involve claims for substantial amounts. Although we may be jointly and severally liable for these costs, in most cases we are only one of a number of PRPs who may also be jointly and severally liable, and among whom costs may be shared or allocated. In addition, we are occasionally named as a party in a number of personal injury lawsuits filed in various jurisdictions alleging claims related to environmental conditions alleged to have resulted from our operations.

Obligations associated with environmental remediation and related matters are difficult to assess and estimate for numerous reasons including the:

●complexity and differing interpretations of governmental regulations,
●number of PRPs and their ability or willingness to fund such allocation of costs,
●financial capabilities of the PRPs and the allocation of costs among them,
●solvency of other PRPs,
●multiplicity of possible solutions,
●number of years of investigatory, remedial and monitoring activity required,
●uncertainty over the extent, if any, to which our former operations might have contributed to the conditions allegedly giving rise to such personal injury, property damage, natural resource and related claims, and
●number of years between former operations and notice of claims and lack of information and documents about the former operations.

In addition, the imposition of more stringent standards or requirements under environmental laws or regulations, new developments or changes regarding site cleanup costs or the allocation of costs among PRPs, solvency of other PRPs, the results of

future testing and analysis undertaken with respect to certain sites or a determination that we are potentially responsible for the release of hazardous substances at other sites, could cause our expenditures to exceed our current estimates. Actual costs could exceed accrued amounts or the upper end of the range for sites for which estimates have been made, and costs may be incurred for sites where no estimates presently can be made. Further, additional environmental and related matters may arise in the future. If we were to incur any future liability, this could have a material adverse effect on our consolidated financial statements, results of operations and liquidity.

We record liabilities related to environmental remediation and related matters (including costs associated with damages for personal injury or property damage and/or damages for injury to natural resources) when estimated future expenditures are probable and reasonably estimable. We adjust such accruals as further information becomes available to us or as circumstances change. Unless the amounts and timing of such estimated future expenditures are fixed and reasonably determinable, we generally do not discount estimated future expenditures to their present value due to the uncertainty of the timing of the payout. We recognize recoveries of costs from other parties, if any, as assets when their receipt is deemed probable.

We do not know and cannot estimate the exact time frame over which we will make payments for our accrued environmental and related costs. The timing of payments depends upon a number of factors, including but not limited to the timing of the actual remediation process; which in turn depends on factors outside of our control. At each balance sheet date, we estimate the amount of the accrued environmental and related costs which we expect to pay within the next twelve months, and we classify this estimate as a current liability. We classify the remaining accrued environmental costs as a noncurrent liability.

The table below presents a summary of the activity in our accrued environmental costs during the first six months of 2025.

​ · ​ · ​ · ​
​​Amount
​ · (In millions)
​ · ​ · ​ · ​
Balance at the beginning of the period​$74.6
Additions charged to expense, net​2.2
Payments, net​(58.2)
Balance at the end of the period​$18.6
Amounts recognized in the Condensed Consolidated Balance Sheet at the end of the period:​
Current liabilities​$4.3
Noncurrent liabilities​14.3
Total​$18.6

*NL –*On a quarterly basis, NL evaluates the potential range of its liability for environmental remediation and related costs at sites where it has been named as a PRP or defendant. At June 30, 2025, NL had accrued approximately $13 million related to approximately 29 sites associated with remediation and related matters it believes are at the present time and/or in their current phase reasonably estimable. The upper end of the range of reasonably possible costs to NL for remediation and related matters for which NL believes it is possible to estimate costs is approximately $38 million, including the amount currently accrued.

In February 2025, the United States District Court for the District of New Jersey entered an order approving a consent decree relating to the Raritan Bay Slag Superfund Site (“RBS Site”) in Middlesex County, New Jersey. The consent decree required the United States Army Corps of Engineers (and other federal agencies), the State of New Jersey, the Township of Old Bridge, NL, andtwenty-two other private companies to pay a total of $151.1 million, plus interest, to resolve all federal and state law claims for past and future response costs under CERCLA and the New Jersey Spill Act, including natural resource damages, contribution, and indemnification, relating to the RBS Site. The consent decree is a global settlement of all such claims relating to the RBS Site and resolves a lawsuit captionedUnited States of America, et al. v. NL Industries, Inc., et al. (United States District Court for the District of New Jersey, Civil Action No. 3:24-cv-08946) as well as all claims asserted by NL and the other settling parties in NL’s previously filed contribution lawsuit,NL Industries, Inc. v. Old Bridge Township, et al.

Under the terms of the consent decree, in the first quarter of 2025 NL paid $56.1 million, plus $.5 million interest, toward the global settlement and received approximately $9.6 million from the other private companies participating in the settlement. We recognized aggregate income of approximately $31.4 million in the fourth quarter of 2024 related to the adjustment of NL’s environmental accrual related to this matter and recorded a $9.6 million receivable for the funds which NL received in the first quarter of 2025 from the other private companies participating in the settlement.

NL believes that it is not reasonably possible to estimate the range of costs for certain sites. At June 30, 2025, there were

approximately five sites for which NL is not currently able to reasonably estimate a range of costs. For these sites, generally the investigation is in the early stages, and NL is unable to determine whether or not NL actually had any association with the site, the nature of its responsibility, if any, for the contamination at the site, if any, and the extent of contamination at and cost to remediate the site. The timing and availability of information on these sites is dependent on events outside of NL’s control, such as when the party alleging liability provides information to NL. At certain of these previously inactive sites, NL has received general and special notices of liability from the EPA and/or state agencies alleging that NL, sometimes with other PRPs, is liable for past and future costs of remediating environmental contamination allegedly caused by former operations. These notifications may assert that NL, along with any other alleged PRPs, is liable for past and/or future clean-up costs. As further information becomes available to us for any of these sites which would allow us to estimate a range of costs, we would at that time adjust our accruals. Any such adjustment could result in the recognition of an accrual that would have a material effect on our consolidated financial statements, results of operations and liquidity.

Other** –**We have also accrued approximately $5 million at June 30, 2025 for other environmental cleanup matters which represents our best estimate of the liability.

Insurance coverage claims – NL

NL is involved in certain legal proceedings with a number of its former insurance carriers regarding the nature and extent of the carriers’ obligations to NL under insurance policies with respect to certain lead pigment and asbestos lawsuits. The issue of whether insurance coverage for defense costs or indemnity or both will be found to exist for NL’s lead pigment and asbestos litigation depends upon a variety of factors, and we cannot assure you that such insurance coverage will be available.

NL has agreements with certain of its former insurance carriers pursuant to which the carriers reimburse it for a portion of its future lead pigment litigation defense costs and one such carrier reimburses us for a portion of NL’s future asbestos litigation defense costs. We are not able to determine how much NL will ultimately recover from these carriers for defense costs incurred by NL because of certain issues that arise regarding which defense costs qualify for reimbursement. While NL continues to seek additional insurance recoveries, we do not know if we will be successful in obtaining reimbursement for either defense costs or indemnity. Accordingly, we recognize insurance recoveries in income only when receipt of the recovery is probable and we are able to reasonably estimate the amount of the recovery.

For a complete discussion of certain litigation involving NL and certain of its former insurance carriers, refer to our 2024 Annual Report.

Other litigation

In addition to the litigation described above, we and our affiliates are involved in various other environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to our present and former businesses. In certain cases, we have insurance coverage for these items, although we do not expect additional material insurance coverage for our environmental matters. We currently believe the disposition of all of these various other claims and disputes (including asbestos-related claims), individually or in the aggregate, should not have a material adverse effect on our consolidated financial position, results of operations or liquidity beyond the accruals already provided.

Note 17 – Fair value measurements and financial instruments:

The following table summarizes the valuation of our financial instruments recorded on a fair value basis as of December 31, 2024 and June 30, 2025:

​​​​​​​​​​​​
​Fair Value Measurements
​​​​​Quoted​​Significant​​​
​​​​​prices in​​other​​Significant
​​​​​active​​observable​​unobservable
​​​​​markets​​input​​inputs
​​Total​​(Level 1)​​(Level 2)​​(Level 3)
​ · (In millions)
Asset (liability)​​​​​​​​​​​
December 31, 2024:​​​​​​​​​​​
Current marketable securities$1.9​$—​$1.9​$—
Noncurrent marketable securities​5.7​​2.6​​3.1​​—
Earn-out liability (See Note 18)​(4.3)​​—​​—​​(4.3)
June 30, 2025:​​​​​​​​​​​
Current marketable securities$2.4​$—​$2.4​$—
Noncurrent marketable securities​4.7​​2.7​​2.0​​—
Currency forward contract​3.2​​3.2​​—​​—
Earn-out liability (See Note 18)​(4.6)​​—​​—​​(4.6)

See Note 5 for amounts related to our marketable securities.

Currency forward contract– In order to manage currency exchange rate risk associated with the maturity in September 2025 of Kronos’ €75 million 3.75% Senior Secured Notes due 2025, in the first quarter of 2025 Kronos entered into a euro currency forward contract to purchase €25 million at an exchange rate of €1.05 per U.S. dollar. The contract matures in September 2025. The fair value of the currency forward contract is determined using Level 1 inputs based on the currency forward rates quoted by banks or currency dealers. The estimated fair value of the currency forward contract at June 30, 2025 was $3.2 million, which is recognized in accounts and other receivables, net in our Condensed Consolidated Balance Sheet with a corresponding $2.3 and $3.2 million currency transaction gain recognized in our Condensed Consolidated Statement of Income for the three and six months ended June 30, 2025, respectively.

The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure:

​​​​​​​​​​​​​
​ · December 31, 2024 · June 30, 2025
​ · ​ · Carrying · ​ · Fair · ​ · Carrying · ​ · Fair
​ · ​ · amount · ​ · value · ​ · amount · ​ · value
​ · ​ · (In millions)
Cash, cash equivalents and restricted cash equivalents​$378.6​$378.6​$223.0​$223.0
Long-term debt:​​​​​
Kronos fixed rate 9.50% Senior Secured Notes due 2029​​365.4​​403.4​​410.7​​444.3
Kronos fixed rate 3.75% Senior Secured Notes due 2025​78.3​77.9​87.9​87.8
Kronos revolving credit facility​​10.0​​10.0​​37.0​​37.0
LandWell bank note payable​11.4​11.4​11.1​11.1

At June 30, 2025, the estimated market price of Kronos’9.50% Senior Secured Notes due 2029 was €1,079 per €1,000 principal amount, and the estimated market price of Kronos’3.75% Senior Secured Notes due 2025 was €999 per €1,000 principal amount. The fair values of Kronos’ Senior Secured Notes were based on quoted market prices; however, these quoted market prices represented Level 2 inputs because the markets in which the Senior Secured Notes trade were not active. Due to the variable interest rate, the carrying amountof Kronos’ revolving credit facility is deemed to approximate fair value. The fair value of other fixed-rate debt, which represents Level 2 inputs, is deemed to approximate carrying value. See Note 7. Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to fair value. See Notes 3 and 8.

Note 18 – Acquisition of Remaining Joint Venture Interest in LPC:

Effective July 16, 2024 (“Acquisition Date”), Kronos acquired the 50% joint venture interest in LPC previously held by Venator. Prior to the acquisition, Kronos held a 50% joint venture interest in LPC and LPC was operated as a manufacturing joint venture between Kronos and Venator. Kronos acquired the 50% joint venture interest in LPC for consideration of $185 million less a working capital adjustment and an additional earn-out payment of up to $15 million. Kronos accounted for the acquisition of the interest in LPC as a business combination and, as a result of obtaining full control, LPC became a wholly-owned subsidiary of Kronos. The acquisition was financed through a borrowing of $132.1 million under Kronos’ Global Revolver and the remainder paid with cash on hand.

For financial reporting purposes, the assets acquired and liabilities assumed of LPC have been included in our Condensed Consolidated Balance Sheets as of December 31, 2024 and June 30, 2025 and the results of operations and cash flows of LPC have been included in our Condensed Consolidated Statement of Income and Cash Flows in 2025.

Kronos remeasured its existing ownership interest in LPC to its estimated fair value at the Acquisition Date in accordance with ASC 805-10-25, for a business combination achieved in stages (because Kronos previously had an ownership interest in LPC). As a result of such remeasurement, we recognized a pre-tax gain of approximately $64.5 million in the third quarter of 2024. See Note 3 of our Consolidated Financial Statements included in our 2024 Annual Report for additional information. The estimated fair value of the earn-out as of December 31, 2024 and June 30, 2025 is included in other noncurrent liabilities on the Condensed Consolidated Balance Sheets and is the line item captioned earn-out liability in Note 9. Accretion of the earn-out liability was not material in the three or six month periods ended June 30, 2025. There has been no other activity subsequent to the Acquisition Date impacting the fair value of the acquisition earn-out liability.

The following table summarizes the aggregate fair value of the consideration transferred to gain control of LPC, the current estimate for the fair value of Kronos’ existing ownership interest in LPC and the amounts assigned to the identifiable assets acquired and liabilities assumed at the Acquisition Date. The final purchase price allocation indicated below was based upon management’s estimate of the fair value of the acquired assets and assumed liabilities using independent third-party appraiser valuation techniques including income, cost, and market approaches. The total consideration was allocated to the assets acquired and liabilities assumed, with the excess of the consideration over the estimated fair value of the net assets acquired recorded as goodwill. Such final purchase price allocation did not change from the previously-reported preliminary purchase price allocation.

Based on the analysis of the transaction at Acquisition Date, we recognized the following:

​​​
​Amount
​ · (In millions)
Consideration:​​
Cash consideration$185.0
Working capital adjustment​(11.0)
Earn-out liability​4.2
Total fair value of consideration​178.2
​​​
Fair value of investment in TiO2 manufacturing joint venture​178.2
Total$356.4
​​​
Allocation of purchase price to identifiable assets acquired and liabilities assumed:​​
Cash and cash equivalents$21.3
Restricted cash​1.3
Accounts and other receivables, net​.2
Inventories, net​82.0
Prepaid expenses and other​.6
Other assets​10.7
Property and equipment​268.5
Accounts payable and accrued liabilities​(21.7)
Other noncurrent liabilities​(6.4)
Deferred tax liability​(2.7)
Total net identifiable assets acquired​353.8
Goodwill​2.6
Total$356.4

Property and equipment will be depreciated over useful lives of 5 years to 20 years. Goodwill is related to the benefits expected as a result of the acquisition, and of the $2.6 million recorded as goodwill, $.1 million is expected to be deductible for tax purposes.

Note 19 – Recent accounting pronouncements:

In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-09, Income Taxes (Topic 740):Improvements to Income Tax Disclosures. The ASU requires additional annual disclosure and disaggregation for the rate reconciliation, income taxes paid and income tax expense by federal, state and non-U.S. tax jurisdictions. In addition, the standard increases the disclosure requirements for items included in the rate reconciliation that meet a quantitative threshold. The ASU is effective for us beginning with our 2025 Annual Report. The ASU may be applied prospectively; however, entities have the option to apply it retrospectively. We are in the process of evaluating the additional disclosure requirements.

In November 2024, the FASB issued ASU No. 2024-03,Reporting Comprehensive Income - Expense Disaggregation Disclosures. The ASU requires additional information about specific expense categories in the notes to financial statements for both interim and annual reporting periods. The ASU is effective for us beginning with our 2027 Annual Report, and for interim reporting, in the first quarter of 2028, with early adoption permitted. We are in the process of evaluating the additional disclosure requirements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.